TRIKA 0.25MG TABLET 15'S
By TORRENT PHARMACEUTICALS LIMITED
Contains: ALPRAZOLAM 0.25 MG
About TRIKA 0.25MG TABLET 15'S
- TRIKA 0.25MG TABLET 15'S is a prescription medication that belongs to the class of drugs known as benzodiazepines. It is commonly prescribed to treat anxiety disorders, panic disorders, and anxiety associated with depression. TRIKA 0.25MG TABLET 15'S works by enhancing the effects of a neurotransmitter called gamma-aminobutyric acid (GABA) in the brain, which helps to calm the excessive activity in the central nervous system. It is available in tablet form and is typically taken orally.
- The use of TRIKA 0.25MG TABLET 15'S should be closely monitored, as it has the potential to be habit-forming. It is important to take this medication exactly as prescribed by a healthcare professional and to follow the recommended dosage and duration of treatment. Abruptly stopping TRIKA 0.25MG TABLET 15'S can lead to withdrawal symptoms, such as rebound anxiety, insomnia, irritability, and seizures. Therefore, it is generally recommended to gradually reduce the dosage under medical supervision when discontinuing the medication.
- While TRIKA 0.25MG TABLET 15'S can be effective in managing anxiety and panic disorders, it does come with some potential side effects. Common side effects may include drowsiness, dizziness, impaired coordination, and memory problems. Some individuals may also experience paradoxical reactions, such as increased anxiety or aggression. It is important to discuss any concerns or side effects with a healthcare provider to ensure the safe and appropriate use of TRIKA 0.25MG TABLET 15'S.
Uses of TRIKA 0.25MG TABLET 15'S
- Prescribe for Anxiety Disorders
- Prescribe for Panic Disorder
- Prescribe for Anxiety Associated with Depression
- Used to treat Insomnia due to Anxiety
How TRIKA 0.25MG TABLET 15'S Works
- TRIKA 0.25MG TABLET 15'S, a benzodiazepine medication, works by enhancing the activity of a neurotransmitter in the brain called gamma-aminobutyric acid (GABA).
- GABA is an inhibitory neurotransmitter that regulates signal transmission in the nervous system.
- TRIKA 0.25MG TABLET 15'S binds to GABA-A receptors, which are widely distributed throughout the central nervous system.
- TRIKA 0.25MG TABLET 15'S enhances the activity of GABA by binding to GABA-A receptors.
- This enhancement of GABA activity leads to an increase in its inhibitory effects in the brain.
- GABA inhibits or reduces the activity of neurons in the brain.
- By enhancing GABA activity, TRIKA 0.25MG TABLET 15'S strengthens the inhibitory effect, resulting in a calming and sedative effect.
- The increased inhibitory activity in the brain helps reduce excessive neuronal firing associated with anxiety.
- TRIKA 0.25MG TABLET 15'S ability to enhance GABA activity in specific brain regions involved in anxiety regulation contributes to its anxiolytic (anti-anxiety) effects.
Dosage of TRIKA 0.25MG TABLET 15'S Works
- For Children:
- TRIKA 0.25MG TABLET 15'S is generally not recommended for use in children under the age of 18, as its safety and efficacy in pediatric populations have not been well-established. Alternative medications or treatments may be considered for children with anxiety or panic disorders.
- For Adults:
- Anxiety Disorders: The initial dosage typically ranges from 0.25 mg to 0.5 mg taken three times per day. The dosage may be adjusted gradually based on the individual's response and tolerance, up to a maximum daily dose of 4 mg.
- Panic Disorder: The starting dosage is often 0.5 mg taken three times per day. The dosage can be increased incrementally, as needed, up to a maximum daily dose of 10 mg.
Side Effects Of TRIKA 0.25MG TABLET 15'S
- Drowsiness
- Fatigue
- Dizziness
- Cognitive Impairment
- Slurred Speech
- Confusion
- Gastrointestinal Issues
- Dry Mouth
- Changes in Libido
- Withdrawal Symptoms
How to Store TRIKA 0.25MG TABLET 15'S
- Store TRIKA 0.25MG TABLET 15'S at room temperature (68°F to 77°F or 20°C to 25°C).
- Keep TRIKA 0.25MG TABLET 15'S away from extreme heat or cold.
- Protect the medication from moisture by storing it in a dry place.
- Avoid storing TRIKA 0.25MG TABLET 15'S in the bathroom where humidity levels are higher.
Frequently asked questions about TRIKA 0.25MG TABLET 15'S
TRIKA 0.25MG TABLET 15'S is used primarily for the treatment of anxiety disorders, panic disorders, and anxiety associated with depression.
TRIKA 0.25MG TABLET 15'S works by enhancing the activity of the neurotransmitter GABA, which has calming and sedative effects in the brain.
Yes, TRIKA 0.25MG TABLET 15'S has the potential for dependence and addiction, especially with long-term use or misuse.
Common side effects of TRIKA 0.25MG TABLET 15'S include drowsiness, fatigue, dizziness, cognitive impairment, slurred speech, confusion, gastrointestinal issues, dry mouth, changes in libido, and withdrawal symptoms if abruptly stopped.
TRIKA 0.25MG TABLET 15'S is generally not recommended for use in children under the age of 18, as its safety and efficacy in pediatric populations have not been well-established.
TRIKA 0.25MG TABLET 15'S is typically prescribed for short-term use due to its potential for dependence and addiction. The duration of treatment depends on the individual's specific condition and treatment plan.
It is generally not recommended to take TRIKA 0.25MG TABLET 15'S during pregnancy or while breastfeeding, as it may pose risks to the developing fetus or newborn. Pregnant or breastfeeding individuals should consult their healthcare provider for guidance.
Yes, TRIKA 0.25MG TABLET 15'S can interact with other medications, including opioids, alcohol, certain antidepressants, and other central nervous system depressants. These interactions can increase the risk of sedation, respiratory depression, and other adverse effects. It is important to inform your healthcare provider about all medications and substances you are taking to avoid potential interactions.
References related to TRIKA 0.25MG TABLET 15'S
- CDSCO. (2023). Retrieved May 31, 2023, from Cdscoonline.gov.in website: https://cdscoonline.gov.in/CDSCO/Drugs
- FDA APPROVED LABELING FOR XANAX XR Attachment to FDA Approval Letter for NDA 21-434. (n.d.). Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/021434lbl.pdf
Rinkal Surti
Show More
Reviewed on 23 Nov 2022
Rinkal Surti
Reviewed on 23 Nov 2022
Medkart pharmacy is doing good on saving money of customer and good work on aware to people about ge Show More
Pallav Bhatt
Reviewed on 22 Nov 2022
Pallav Bhatt
Reviewed on 22 Nov 2022
Good service. Public relations are very good.
Mitula Patel
Reviewed on 08 Jan 2024
Mitula Patel
Reviewed on 08 Jan 2024
It's a seamless experience.
Kunal Patel
Reviewed on 13 May 2023
Kunal Patel
Reviewed on 13 May 2023
Good place with excellent service and good customer service
Naren oberoi
Reviewed on 23 Nov 2022
Naren oberoi
Reviewed on 23 Nov 2022
Very good service